Evaluation and Management of Weight Gain in Midlife Women

Initial Assessment and Risk Stratification

• The American Heart Association recommends measuring BMI and waist circumference at the initial visit to determine treatment intensity and cardiovascular risk stratification 1, 2
• Waist circumference >35 inches (88 cm) in women indicates central obesity and independently predicts cardiovascular mortality even with normal BMI 1
• Documenting current weight, weight at age 18, and pattern of weight gain over time helps identify critical periods of gain 2
• The American College of Cardiology suggests asking specifically about timing and rate of weight gain to distinguish between secondary causes and lifestyle factors 1, 2

Laboratory Evaluation and Testing

• A comprehensive metabolic panel is essential to evaluate for diabetes, kidney disease, and electrolyte abnormalities 1
• Fasting lipid profile screens for dyslipidemia, which is exacerbated by excess weight 1, 2
• Thyroid function tests (TSH with reflex free T4) help identify hypothyroidism, a common reversible cause of weight gain 1
• Fasting glucose or HbA1c screens for prediabetes and diabetes, particularly important in women aged 40-70 with overweight/obesity 1, 2

Identification of Secondary Causes

• The Endocrine Society recommends considering PCOS in perimenopausal women with irregular menses, hirsutism, or acanthosis nigricans on exam 5, 1, 6
• Women with PCOS have accelerated weight gain compared to unaffected women, with rates increasing from adolescence through midlife 5, 6
• PCOS prevalence increases 9% for every 1-unit BMI increase 6
• The American Association of Clinical Endocrinologists suggests suspecting Cushing's syndrome if a patient has thin/atrophic skin, easy bruising, proximal muscle weakness, wide purple striae, or facial plethora 1

Management and Treatment

• The American Heart Association recommends a 5-10% weight loss over 6-12 months as the initial goal through comprehensive lifestyle intervention 7, 2
• Treatment should involve a multidisciplinary team and last at least 6-12 months with monthly contact 7, 2
• If secondary causes are identified, treating the underlying condition, such as optimizing thyroid replacement for hypothyroidism or considering PCOS-specific management, is crucial 1
• Modifying weight-promoting medications when possible, such as switching to weight-neutral alternatives or adding metformin or topiramate, can help counteract medication-induced gain 3, 4